| Symbol | FPN1 |
| Full Name | Ferroportin 1 |
| Protein | [Ferroportin](/entities/ferroportin-protein) |
| Chromosome | 2q33.1 |
| NCBI Gene ID | 55730 |
| UniProt ID | Q9NP73 |
| Aliases | SLC40A1, FPN1, MTP1, IREG1, SLC11A3 |
Overview
FPN1 (Ferroportin) encodes the sole known cellular iron exporter in mammals, playing a critical role in systemic iron homeostasis and brain iron metabolism.1Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory networkOpen reference Ferroportin mediates iron efflux from cells, preventing intracellular iron accumulation that can drive oxidative damage through the Fenton reaction.2The role of iron in brain ageing and neurodegenerative disordersOpen reference
Structure and Expression
The FPN1 gene spans approximately 25 kb on chromosome 2q33.1 and contains 8 exons encoding a 571-amino acid protein with 12 predicted transmembrane domains.3The iron exporter ferroportin/Slc40a1 is essential for iron homeostasisOpen reference Ferroportin functions as a homodimer at the plasma membrane and is expressed in:
-
Enterocytes: Duodenal iron absorption
-
Macrophages: Recycling of iron from senescent erythrocytes
-
Hepatocytes: Hepatic iron storage and mobilization
-
Neurons and astrocytes: Brain iron homeostasis4Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron effluxOpen reference
Normal Function
Ferroportin serves as the primary cellular iron exporter with the following functions:
-
Iron Export: Transports ferrous iron (Fe²⁺) across cell membranes
-
HEPCIDIN Regulation: Binds hepcidin, which induces internalization and degradation
-
Iron Homeostasis: Maintains appropriate cellular iron levels
-
Placental Iron Transfer: Essential for maternal-fetal iron transport5Ironing out FerroportinOpen reference
Role in Neurodegeneration
Brain Iron Homeostasis
Ferroportin is essential for maintaining brain iron balance, working in concert with transferrin receptors, DMT1, and ceruloplasmin to regulate iron trafficking across the blood-brain barrier and between neural cells.6Iron trafficking inside the brainOpen reference Dysregulation of ferroportin expression or function contributes to pathological iron accumulation observed in neurodegenerative diseases.
Parkinson’s Disease
In Parkinson’s disease, iron accumulates in the substantia nigra where dopaminergic neurons degenerate. Ferroportin expression is reduced in PD brains, contributing to iron retention and oxidative stress.7Ceruloplasmin dysfunction and therapeutic potential for Parkinson diseaseOpen reference Iron promotes alpha-synuclein aggregation and enhances neurotoxicity through ferroptosis.
Alzheimer’s Disease
Alzheimer’s disease is characterized by iron accumulation in amyloid plaques and neurofibrillary tangles. Ferroportin co-localizes with amyloid-beta plaques, and reduced ferroportin activity may exacerbate iron-mediated oxidative damage and tau pathology.8Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairmentOpen reference
NBIA Type 4
Loss-of-function mutations in FPN1 cause Neurodegeneration with Brain Iron Accumulation Type 4 (NBIA4), an autosomal dominant disorder characterized by progressive iron accumulation in the basal ganglia, cerebellum, and cerebral white matter, leading to movement disorders and cognitive decline.9Functional and clinical impact of novel ferroportin mutationsOpen reference
Molecular Mechanisms
HEPCIDIN-Ferroportin Axis
Hepcidin, the systemic iron regulatory hormone, binds ferroportin and induces its internalization and lysosomal degradation, thereby reducing iron export.10Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalizationOpen reference In neurodegeneration, elevated hepcidin levels (due to inflammation) may suppress ferroportin, promoting neuronal iron accumulation.
Ferroptosis
Ferroportin dysfunction contributes to ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation. Excess intracellular iron catalyzes the generation of reactive oxygen species, leading to membrane damage and cell death—a process implicated in PD, AD, and ALS.2The role of iron in brain ageing and neurodegenerative disordersOpen reference0
Therapeutic Implications
-
Iron Chelation: Deferiprone and deferoxamine reduce brain iron burden
-
Hepcidin Antagonism: Blocking hepcidin-ferroportin interaction may restore iron export
-
Ferroptosis Inhibition: Ferrostatin-1 and liproxstatin-1 prevent iron-dependent cell death
-
Gene Therapy: Restoring ferroportin expression in affected brain regions2The role of iron in brain ageing and neurodegenerative disordersOpen reference1
Key Interactions
| Protein | Relationship | Function |
|---|---|---|
| HEPCIDIN | Ligand | Induces ferroportin internalization |
| Ceruloplasmin | Partner | Oxidizes Fe²⁺ to Fe³⁺ for export |
| DMT1 | Opposing | Imports iron into cells |
| Ferritin | Storage | Stores excess cellular iron |
See Also
External Links
References
- Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network
- The role of iron in brain ageing and neurodegenerative disorders
- The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
- Ferroportin and exocytoplasmic ferroxidase activity are required for brain microvascular endothelial cell iron efflux
- Ironing out Ferroportin
- Iron trafficking inside the brain
- Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
- Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment
- Functional and clinical impact of novel ferroportin mutations
- Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
- Ferroptosis: A Regulated Cell Death Nexus Connecting Metabolism, Redox Biology, and Disease
- Targeting chelatable iron as a therapeutic modality in Parkinson's disease
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.